The Greater Cannabis Company, Inc.
OTC: GCAN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Pink Sheets LLC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Aitan Zacharin
- Employees
- 1
- Headquarters
- Baltimore, United States
- IPO year
- 2018
- Market cap
- $173.7K
- Website
- https://www.gcanrx.com
Loading GCAN…
Loading profile data…Frequently asked questions about GCAN
What does The Greater Cannabis Company, Inc. (GCAN) do?
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schiz...
Where does GCAN trade?
The Greater Cannabis Company, Inc. (GCAN) trades on the Pink Sheets LLC.
What sector is GCAN in?
The Greater Cannabis Company, Inc. (GCAN) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of The Greater Cannabis Company, Inc.?
Aitan Zacharin is the chief executive officer of The Greater Cannabis Company, Inc. (GCAN).
Where is The Greater Cannabis Company, Inc. headquartered?
The Greater Cannabis Company, Inc. is headquartered in United States.
Does GCAN pay a dividend?
The Greater Cannabis Company, Inc. (GCAN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GCAN go public?
The Greater Cannabis Company, Inc. (GCAN) completed its initial public offering in 2018.